Gilead-Backed Stem Cell Startup Beats Patent Suit
A stem cell research startup funded by Gilead Sciences has beaten a suit from an MIT-backed rival alleging the startup infringed patents covering a stem cell process developed by a top professor...To view the full article, register now.
Already a subscriber? Click here to view full article